Innovative nanotechnologies in the diagnosis and treatment of myocardial infarction: new horizons and perspectives

Kuat Sultan, Kumar Akku, Beksultan Abdalimov, Gulzhazira Mirzamuratova, Aruzhan Mendybayeva

2023

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.51582/interconf.19-20.12.2023.039
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Nanotechnologies in the field of diagnosing and treating myocardial infarction represent a rapidly evolving area. Polymer nanoparticles demonstrate promising potential in enhancing diagnostic accuracy and therapeutic effectiveness, serving as tools for detecting biomarkers and stimulating heart cell regeneration. These innovative methods, based on microRNA, liposomes, and M2 macrophages, offer prospects for novel strategies in cardiovascular disease treatment. Such innovative approaches to delivering microRNA that stimulates heart cell regeneration have the potential to improve heart function post-infarction. Overall, research in polymer nanoparticles paves the way for further clinical studies aimed at developing innovative methods for diagnosing and treating myocardial infarction.